跳至主要内容
临床试验/NCT07144332
NCT07144332招募中不适用

Assessment of the Efficacy of Hemodialysis on Uric Acid Clearance at End Stage Kidney Disease in Sohag University Hospital

Sohag University1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2025年7月13日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
100
试验地点
1
主要终点
study of serum uric acid level in hemodialysis patients

研究概览

简要总结

Background: Uricemia dramatically rises with the stage of chronic kidney disease (CKD) and correlates with its mortality. Hemodialysis (HD) being the most used treatment at the end stage kidney disease in Sohag governorate , we sought to evaluate its efficacy on the clearance of uric acid (UAc) when used alone and twice per week.

Methods: A cross-sectional study of all consenting patients with CKD stage 5 recruited at random during hemodialysis sessions at hemodialysis unit in Sohag university hospital from July to December 2025. We collected socio-demographic data, relevant clinical information, hemodialysis related variables, and measured serum uric acid (SUA) levels before and after the dialysis to assess the uric acid clearance. A clearance between 65 and 80% and above 80% was considered as low and good efficacy of hemodialysis respectively

详细描述

Aim of the the work The aim of this study is to estimate the efficacy of Hemodialysis alone for uric acid clearance in patients on hemodialysis. In order to evaluate the need of adjuvant uric acid lowering therapy

Patients And Methods

  1. Type of The study:

Prospective cross-sectional study. 2. Place of the study:

Sohag University Hospital, department of Internal Medicine and hemodialysis unit. 3. Ethical aspect:

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • We included all consenting adults aged 18 or older, on maintenance hemodialysis for at least 3 consecutive months receiving 2 to 3 sessions weekly

排除标准

  • Patients aged < 18 years old .
  • Patients on recent hemodialysis less than 3 months.
  • We excluded patients who were on Uric acid lowering therapy (UALT).
  • Patients received less than 4 hours of hemodialysis and those who had emergency dialysis.

结局指标

主要结局

study of serum uric acid level in hemodialysis patients

时间窗: during hemodialysis session 2 to 3 hours

milligrams per deciliter (mg/dL)

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Reham Hussien Abotaleb

Internal medicine resident doctor

Sohag University

研究点 (1)

Loading locations...

相似试验